RASSF1 and hepatocellular carcinoma: The assessment of the methylation status of RASSF1A had a sensitivity of 65.0%, specificity of 70.0%, PPV of 68.42%, NPV of 66.67%, and accuracy of 67.50% in detecting HCC in cirrhotic patients (Figure 1).